CD4 and breast carcinoma: Comparing to 30 other cancer types, our analysis reveals that the interaction effects of HRD only manifest in breast cancer, typically promoting the beneficial survival effect of T cell, CD4 T cell, Tregs, and Th cell (Figure 6B).